Insights

Perspectives on law,
business and governance.

Thought leadership from our lawyers on the legal and commercial issues shaping business today. Explore our latest publications below.

26 OCT 2026

When Pharma Uses AI: Who Owns the Risk?

Malaysia’s emerging AI and data-protection framework puts renewed focus on accountability when AI enters regulated pharmaceutical processes.

20 OCT 2026

On the Board of a Malaysian Subsidiary? Your Multinational Group’s Anti-Bribery Policy May Not Protect You

Parent-appointed directors and relevant executives may face personal exposure under section 17A. A group anti-bribery policy is only the starting point.

02 OCT 2026

Human Rights Due Diligence: Why It Matters for Japanese Manufacturers in Malaysia

Human rights due diligence is increasingly becoming a business expectation shaped by customer requirements, supply chain governance standards, Malaysian policy developments and international trade measures.

Perspectives on law,business and governance.

When Pharma Uses AI: Who Owns the Risk?

On the Board of a Malaysian Subsidiary? Your Multinational Group’s Anti-Bribery Policy May Not Protect You

Human Rights Due Diligence: Why It Matters for Japanese Manufacturers in Malaysia

Let's start a conversation.

Perspectives on law,
business and governance.